Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohort

Scandinavian Journal of Gastroenterology
Pascal JuilleratEC-IBD Group

Abstract

The European Panel on the Appropriateness of Crohn's disease Therapy (EPACT) has developed appropriateness criteria. We have applied these criteria retrospectively to the population-based inception cohort of Crohn's disease (CD) patients of the European Collaborative Study Group on Inflammatory Bowel Disease (EC-IBD). A total of 426 diagnosed CD patients from 13 European centers were enrolled at the time of diagnosis (first flare, naive patients). We used the EPACT definitions to identify 247 patients with active luminal CD. We then assessed the appropriateness of the initial drug prescription according to the EPACT criteria. Among the cohort patients 163 suffered from mild-to-moderate CD and 84 from severe CD. Among the mild-to-moderate disease group, 96 patients (59%) received an appropriate treatment, whereas for 66 patients (40%) the treatment was uncertain and in one case (1%) inappropriate. Among the severe disease group, 86% were treated medically and 14% required surgery. 59 (70%) were appropriately treated, whereas for one patient (1%) the procedure was considered uncertain and for 24 patients (29%) inappropriate. Initial treatment was appropriate in the majority of cases for non-complicated luminal CD. Inappropriate o...Continue Reading

References

Sep 1, 2000·European Journal of Internal Medicine·R W StockbrüggerS Shivananda
Dec 21, 2000·Alimentary Pharmacology & Therapeutics·G P RubinJ Ling
Dec 31, 2003·The American Journal of Gastroenterology·William J Sandborn
May 1, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Stephen B Hanauer, Ulf Strömberg
Jun 3, 2005·The American Journal of Gastroenterology·Sarathchandra I ReddyPeter A Banks
Jan 28, 2006·World Journal of Gastroenterology : WJG·Annika Lapidus
Sep 6, 2006·Gastroenterology·Selwyn OdesUNKNOWN European Collaborative Study on Inflammatory Bowel Disease
Sep 11, 2008·International Journal of Epidemiology·Valérie PittetUNKNOWN Swiss IBD Cohort Study Group
Jan 29, 2009·The American Journal of Gastroenterology·Gary R LichtensteinUNKNOWN Practice Parameters Committee of American College of Gastroenterology
Jun 18, 2009·The American Journal of Gastroenterology·Josh MarehbianWilliam J Sandborn
Sep 15, 2009·World Journal of Gastroenterology : WJG·Peter Laszlo Lakatos
Sep 30, 2009·Digestive Diseases·Simon Bar-Meir
Apr 16, 2010·The New England Journal of Medicine·Jean Frédéric ColombelUNKNOWN SONIC Study Group
Dec 3, 2010·Journal of Crohn's & Colitis·A DignassUNKNOWN European Crohn's and Colitis Organisation (ECCO)
Jun 1, 2008·Journal of Crohn's & Colitis·Pascal JuilleratPierre Michetti
Dec 22, 2010·Journal of Crohn's & Colitis·Pierre MichettiUNKNOWN EPACT II Study Group
Dec 22, 2010·Journal of Crohn's & Colitis·Pascal JuilleratUNKNOWN EPACT II Study Group
Dec 22, 2010·Journal of Crohn's & Colitis·Christian FelleyUNKNOWN EPACT II Study Group

❮ Previous
Next ❯

Citations

Aug 30, 2014·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Stephan R VavrickaLuc Biedermann
Jan 1, 2013·Case Reports in Hepatology·Yuka MiyakeKojiro Michitaka
Jun 6, 2015·International Journal of Epidemiology·Tim Ra van den HeuvelMarie J Pierik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.